ByTrending Posts
Can Labcorp’s AI-Powered Test Finder Redefine Diagnostic Efficiency…
Key Highlights Expansion Into Clinical WorkflowsLabcorp (NYSE: LH) announced the integration of its AI-driven Test Finder into Labcorp…
Can Ambience Healthcare’s $243M Series C Push the…
Key Highlights Record Funding and Unicorn StatusAmbience Healthcare, founded in 2020 in San Francisco, announced a $243 million…
How Is Roche’s Expansive 2025 Pipeline and Innovative…
Key Highlights: Broad and Deep Pharmaceutical Pipeline ExpansionSince mid-2023, Roche has significantly enhanced its clinical pipeline, adding 24…
Could Eli Lilly’s $1.3 Billion GPCR Deal with Superluminal Medicines Unlock a…
Key Highlights Eli Lilly Taps AI-Powered Drug Discovery in Landmark GPCR Agreement Eli Lilly has entered a global…
How Will Bayer’s $1.3 Billion Bet on KRAS G12D…
Key Highlights Bayer Targets KRAS G12D Mutation with Landmark Licensing Deal Bayer has entered a global exclusive licensing…
Can GSK’s Gepotidacin Priority FDA Review and Strategic…
Key Highlights: FDA Priority Review of Gepotidacin for GonorrhoeaGSK submitted a supplemental New Drug Application for gepotidacin, targeting…
Why Is Eli Lilly’s 2025 Outlook Soaring Despite…
Key Highlights: Strong Sales Growth and Raising GuidanceEli Lilly posted impressive Q2 2025 earnings surpassing estimates, largely on…
Why Could Novartis’ Ianalumab, With Dual Mechanism of B-Cell Depletion and BAFF-R…
Key Highlights: Positive Phase III Results Confirm Efficacy in Sjögren’s DiseaseThe NEPTUNUS-1 (275 patients) and NEPTUNUS-2 (504 patients)…
Can AstraZeneca’s $50 Billion U.S. Investment and Drug…
Key Highlights: Strategic Response to U.S. Pricing PressuresAstraZeneca CEO Pascal Soriot announced proactive proposals for U.S. drug price…
Trending Posts
Latest Stories
Takeda Announces Positive Phase III Results for AI-Discovered Oral Psoriasis Therapy
Tokyo, Japan – December 19, 2025 – Takeda Pharmaceutical Company Limited today announced successful results…
Geneva inaugurates first artificial intelligence health hub at Campus Biotech
GENEVA, Dec. 8, 2025 — Geneva has officially inaugurated its first artificial intelligence health hub…
Cradle AI-powered protein engineering platform serving six of the top 25 global pharma leaders
AMSTERDAM and ZURICH, Dec. 16, 2025 — Cradle, an enterprise-grade AI software platform for protein…
Adaptive Biotechnologies and Pfizer Announce Strategic Research Collaboration Valued Up to $890 Million to Advance Breakthrough Therapies for Rheumatoid Arthritis and Immune-Mediated Diseases
A target discovery agreement to identify disease-specific T-cell receptors (TCRs) in rheumatoid arthritis. A data…
Gallery
